Home > Press > Test of maturity for stem cells
Abstract:
Stem cells can differentiate into 220 different types of body cell. The development of these cells can now be systematically observed and investigated with the aid of two new machines that imitate the conditions in the human body with unprecedented accuracy.
Test of maturity for stem cells
Stem cells can differentiate into 220 different types of body cell. The development of these cells can now be systematically observed and investigated with the aid of two new machines that imitate the conditions in the human body with unprecedented accuracy.
Stem cells are extremely versatile: They can develop in 220 different ways, transforming themselves into a correspondingly diverse range of specialized body cells. Biologists and medical scientists plan to make use of this differentiation ability to selectively harvest cardiac, skin or nerve cells for the treatment of different diseases. However, the stem cell culture techniques practiced today are not very efficient. What proportion of a mass of stem cells is transformed into which body cells? And in what conditions? "We need devices that keep doing the same thing and thus deliver statistically reliable data," says Professor Günter Fuhr, director of the Fraunhofer Institute for Biomedical Engineering IBMT in St. Ingbert.
Two prototypes of laboratory devices for stem cell differentiation enable the complex careers of stem cells to be systematically examined for the first time ever. These devices are the result of the international project ‘CellPROM' - ‘Cell Programming by Nanoscaled Devices' - which was funded by the European Union to the tune of 16.7 million euros and coordinated by the IBMT. "The type of cell culture used until now is too far removed from the natural situation," says CellPROM project coordinator Daniel Schmitt - for in the body, the stem cells come into contact with solute nutrients, messenger RNAs and a large number of different cells. Millions of proteins rest in or on the cell membranes and excite the stem cells to transform themselves into specialized cells. "We want to provide the stem cells in the laboratory with a surface that is as similar as possible to the cell membranes," explains Daniel Schmitt. "To this end, the consortium developed a variety of methods by which different biomolecules can be efficiently applied to cell-compatible surfaces."
In the two machines - MagnaLab and NazcaLab - the stem cells are brought into contact with the signal factors in a pre-defined manner. In MagnaLab, several hundred cells grow on culture substrates that are coated with biomolecules. In NazcaLab, large numbers of individual cells, washed around by a nutrient solution, float along parallel channels where they encounter micro-particles that are charged with signal factors. "We use a microscope and a camera to document in fast motion how individual cells divide and differentiate," says Schmitt. The researchers demonstrated on about 20 different cell models that the multi-talents can be stimulated by surface signals to transform themselves into specialized cells.
####
About Fraunhofer Society
The Fraunhofer-Gesellschaft undertakes applied research of direct utility to private and public enterprise and of wide benefit to society.
For more information, please click here
Contacts:
Dipl.-Phys. Daniel Schmitt
Phone: +49 6894 980-120
Fax: +49 6894 980-400
Send an e-mail
Fraunhofer-Institut für Biomedizinische Technik
IBMT
Ensheimer Straße 48
66386 St. Ingbert
Copyright © Fraunhofer Society
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||